ALERT: Due to the inclement weather across much of the country, Medtronic deliveries are currently experiencing delays and there will be longer than normal hold times on the phone. Visit www.Diabetes.shop if you need to place an order, get a sensor or belt clip replacement, or check the status of your supply order. X
MiniMed 780G

MiniMed 780G system and new CGM are under FDA review


Our goal is to reduce fingersticks and bring you an advanced algorithm with auto correction bolus soon


Don't want to wait?

       

AUTHORIZATION FOR USE OF PROTECTED HEALTH INFORMATION

You authorize Medtronic MiniMed, Inc. d/b/a Medtronic Diabetes or its subsidiaries, contractors or representatives to use your personal information, including but not limited to your contact information and health information, for marketing purposes and to share that information with Medtronic representatives and contractors. Information you may receive includes, but is not limited to: (a) Medtronic Diabetes products, therapies or services; (b) marketing and promotional offers; (c) inquiries about your experience with Medtronic Diabetes products, therapies and services; and/or (d) suggestions for how Medtronic Diabetes can enhance its customer support.

This authorization will expire three (3) years from the later of the date you submit this authorization online; or (ii) the last date products or services were received from Medtronic, but may expire sooner if you revoke it by following the instructions below.

You have the right to revoke this authorization at any time by (i) e-mailing takecontrol@medtronic.com; or (ii) signing into your myHome profile and updating my communication preferences at www.diabetes.shop/myhome. A revocation will not affect actions Medtronic Diabetes has already taken based on this authorization. Information disclosed pursuant to this authorization may be re-disclosed by the recipient of the information and may no longer be protected by the federal privacy standards.

You have the right to refuse to sign this authorization. Refusal to sign will not affect your treatment or health insurance eligibility or benefits.

Questions? Contact our Customer Service Center at 800-646-4633, or by email at takecontrol@medtronic.com.

CONSENT FOR RECEIPT OF PHONE COMMUNICATIONS

You consent to receiving phone calls, including pre-recorded and auto-dialed communications, at the phone number(s) submitted above using automated technology from or on behalf of Medtronic MiniMed, Inc. d/b/a Medtronic Diabetes, concerning the marketing, advertising and/or offers of sale of Medtronic Diabetes products, therapies and services. You also certify that you are (a) age 18 and older and (b) authorizing and consenting to use of the information provided for Medtronic Diabetes to contact you. Your consent is not a condition for purchase. Airtime, message and data rates may apply. You may opt out at any time by (i) e-mailing takecontrol@medtronic.com; or (ii) signing into your myHome profile and updating your communication preferences (www.diabetes.shop/myhome).

CONSENT FOR RECEIPT OF TEXT COMMUNICATIONS

You consent to receiving text messages at the phone number(s) submitted above using automated technology from or on behalf of Medtronic MiniMed, Inc. d/b/a Medtronic Diabetes, concerning the marketing, advertising and/or offers of sale of Medtronic Diabetes products, therapies and services. You also certify that you are (a) age 18 and older and (b) authorizing and consenting to use of the information provided for Medtronic Diabetes to contact you. Your consent is not a condition for purchase. Airtime, message and data rates may apply. You may opt out at any time by (i) texting "STOP" in return to a text; (ii) sending an email to takecontrol@medtronic.com; or (iii) signing into your myHome profile and updating your communication preferences (www.diabetes.shop/myhome).

Programs for customers with an in-warranty Medtronic pump


Most insulin pumps have a standard 4-year replacement warranty.


Lift ticket


If you purchased a MiniMed insulin pump between November 14, 2018 and April 11, 2019, you may be eligible to upgrade to our latest technology for only $99. As of 2/2/21, the $400 deposit is no longer required.1


Pathway


If you have a MiniMed insulin pump with more than 6 months warranty remaining you may be eligible to upgrade to our latest technology for only $399. As of 2/2/21, the $400 deposit is no longer required.2


Don’t have an in-warranty Medtronic pump? We have options for you too!

Customers with out-of-warranty MiniMed pumps


If you have an out-of-warranty Medtronic insulin pump you may upgrade to our latest technology and receive a $500 trade-in credit for your current Medtronic pump.3

Customers with in-warranty MiniMed™ transmitters


If you are currently using an in-warranty transmitter not compatible with one of our MiniMed™ insulin pump systems, you may upgrade to an insulin pump and pay $0 for a new compatible transmitter.4

Not yet a Medtronic customer?


If you are using an in-warranty pump from another company, you may upgrade to our latest technology for up to $499.2 And, if you are using an in-warranty transmitter from another company, you may upgrade to our latest transmitter technology for up to $100.5

PROGRAMS TERMS AND CONDITIONS:

1. Lift Ticket
  • $99 charge will be required upfront to use Lift Ticket. Return of old insulin pump is required. If old pump not returned, customer will be charged $3,200.
  • After you have requested to use your Lift Ticket, it could take up to 60 days to process your order. The Lift Ticket Program does not guarantee prioritization of your order.
  • Lift Ticket can only be redeemed once during your Replacement warranty period. A Lift Ticket cannot be redeemed if less than six (6) months remains on your pump warranty period.
  • The Lift Ticket Program price applies to (1) insulin pump. CGM products and consumables are not included.
  • Insurance coverage and approvals may impact patient ability to upgrade. Coverage for your pump is contingent upon your payer medical policy guidelines. Restrictions and medical necessity requirements apply.
  • Warranty dates do not reset. The Replacement warranty date of an upgraded insulin pump will remain the same as the Replacement warranty date of the initial pump purchased.
  • Patients enrolled in a rental program must complete their final payment and own their pump before utilizing the Lift Ticket program.
  • MiniMed pumps have certain labeling restrictions that may exclude certain populations, including age and type of diabetes. We recommend you consult your Healthcare Provider.
  • A valid prescription will be required to purchase a new pump. Other restrictions may apply.
  • Program terms and conditions are subject to change at any time and without notice.
  • Any purchase for a patient with Out of Warranty pump or new to pump therapy of a Medtronic insulin pump that shipped between 11/14/18 and 4/11/19 is eligible to receive a Lift Ticket.

2. Pathway & Switch 2 System
  • Customers with more than six months remaining on their warranty are eligible for the Pathway Program.
  • The Pathway Program is for pump upgrades only. CGM, if required or requested, must be purchased separately.
  • The Pathway Program does not extend the Replacement warranty period. The customer’s current warranty timeline will not change by purchasing a pump through this program.
  • Customers will need to verify that their payer will support transitioning to the new pump, as it could affect ongoing coverage of their future pump supplies.
  • Customers must return their old pump within 30 days. Patients who do not return their pump will be charged $3,200.
  • Pricing, terms, and conditions are subject to change at any time and without notice.
  • $500 credit for Medtronic pump, Tandem® pump, Animas® pump, or Roche® pump. $250 credit for Omnipod® receiver.

3. Pump Trade-in
  • This program is only available for out-of-warranty MiniMed™ insulin pump customers
  • Failure to return your old MiniMed™ pump will disqualify you for the $500 Pump Trade-in Program credit, and you will be responsible for the full cost of the Medtronic pump.

4. SmartStep
  • A prescription from a healthcare provider for CGM therapy is required.
  • Customers must have an in-warranty Guardian Connect transmitter.
  • Customer must pay $200 for the new transmitter. Once the customer returns their Guardian Connect transmitter, and Medtronic will refund the $200.
  • The following patient groups will not be eligible for the Transmitter Pathway Program:
  • o Patients who have no CGM coverage including Medicare, Medicaid, and other government payers
  • Program terms and conditions are subject to change at any time and without notice.

5. Transmitter Pathway Program
  • A prescription from a healthcare provider for CGM therapy is required.
  • Customers must have an in-warranty transmitter.
  • Customers will pay $300 out-of-pocket to purchase a Medtronic CGM transmitter and a (1) 5-pack of sensors.
  • Upon receipt of payment, Medtronic will ship (1) transmitter and a (1) 5-pack of sensors.
  • If patient returns their old transmitter to Medtronic, the patient will receive a $200 trade-in credit. The credit will be applied to their original payment method.
  • If customer does not return your in-warranty transmitter, they will not receive a $200 credit back.
  • The following patient groups will not be eligible for the Transmitter Pathway Program:
  • o Abbott Libre is a disposable CGM system. Therefore, these patients are not eligible
    o Patients who have no CGM coverage including Medicare, Medicaid, and other government payers
  • Program terms and conditions are subject to change at any time and without notice.

* Software Upgrade Terms and Conditions:
  • This program allows MiniMed 770G system customers a software upgrade at no charge through. October 27, 2022.
  • Software upgrade process is subject to change and may result in healthcare provider office visit and may result in out-of-pockets expenses such as co-pay, depending on insurance coverage.
  • MiniMed pumps and software have certain labeling restrictions that may exclude certain populations, including age and type of diabetes. We recommend you consult your healthcare provider regarding your eligibility to receive the software upgrade based on the labeling of the upgrade, which may differ from the labeling of the MiniMed 770G pump.
  • This program applies to the insulin pump software only. Continuous Glucose Monitor products and consumables are not included in this offer.
  • A valid prescription will be required for this software upgrade. All participants should consult their healthcare provider for all therapy related decisions.
  • Warranty dates do not reset. The replacement warranty date of an insulin pump upgraded with the software will remain the same as the replacement warranty date of the initial pump purchased.
  • Insurance coverage and plan design varies and may impact the ability to upgrade. Coverage is contingent upon your health insurance medical policy guidelines. Restrictions and medical necessity requirements may apply.
  • Program terms and conditions are subject to change at any time and without notice. Other restrictions may apply.


Important Safety Information: MiniMed 770G System With SmartGuard Technology
The MiniMed 770G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons two years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed 770G System includes SmartGuard technology, which can be programmed to automatically adjust delivery of basal insulin based on continuous glucose monitoring (CGM) sensor glucose (SG) values and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values.

The Medtronic MiniMed 770G System consists of the following devices: MiniMed 770G Insulin Pump, the Guardian Link (3) Transmitter, the Guardian Sensor (3), one-press serter, the Accu-Chek® Guide Link blood glucose meter, and the Accu-Chek® Guide Test Strips. The system requires a prescription.

The Guardian Sensor (3) has not been evaluated and is not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. All therapy adjustments should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian Sensor (3).

All therapy adjustments should be based on measurements obtained using the Accu-Chek® Guide Link blood glucose meter and not on values provided by the Guardian Sensor (3). Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the Accu-Chek® Guide Link blood glucose meter. Do not calibrate your CGM device or calculate a bolus using a blood glucose meter result taken from an alternative site. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise.

WARNING: Do not use the SmartGuard Auto Mode for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in SmartGuard Auto Mode.

WARNING: Do not use the MiniMed 770G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed 770G system.

Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. The safety of the MiniMed 770G system has not been studied in pregnant women. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult https://www.medtronicdiabetes.com/important-safety-information#minimed-770g and the appropriate user guide at http://www.medtronicdiabetes.com/download-library

Important Safety Information: MiniMed 670G System
The Medtronic MiniMed 670G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons, seven years of age and older, requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed 670G system includes SmartGuard technology, which can be programmed to automatically adjust delivery of basal insulin based on Continuous Glucose Monitor sensor glucose values and can suspend delivery of insulin when the sensor glucose value falls below or is predicted to fall below predefined threshold values. The system requires a prescription. The Guardian Sensor (3) glucose values are not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. A confirmatory finger stick test via the CONTOUR®NEXT LINK 2.4 blood glucose meter is required prior to making adjustments to diabetes therapy. All therapy adjustments should be based on measurements obtained using the CONTOUR®NEXT LINK 2.4 blood glucose meter and not on values provided by the Guardian Sensor (3). Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the CONTOUR®NEXT LINK 2.4 blood glucose meter. Do not calibrate your CGM device or calculate a bolus using a blood glucose meter result taken from an Alternative Site (palm) or from a control solution test. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise. If a control solution test is out of range, please note that the result may be transmitted to your pump when in the “Always” send mode.

WARNING: Medtronic performed an evaluation of the MiniMed 670G system and determined that it may not be safe for use in children under the age of 7 because of the way that the system is designed and the daily insulin requirements. Therefore this device should not be used in anyone under the age of 7 years old. This device should also not be used in patients who require less than a total daily insulin dose of 8 units per day because the device requires a minimum of 8 units per day to operate safely.

Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. The safety of the MiniMed™ 670G system has not been studied in pregnant women. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult http://www.medtronicdiabetes.com/important-safety-information#minimed-670g and the appropriate user guide at http://www.medtronicdiabetes.com/download-library

Important Safety Information: Guardian Connect CGM System
The Guardian Connect system requires a prescription and is indicated for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin, in patients (14 to 75 years of age) with diabetes mellitus. The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices, and is not recommended for people who are unwilling or unable to perform a minimum of two meter blood glucose tests per day, or for people who are unable or unwilling to maintain contact with their healthcare professional. The system requires a functioning mobile electronic device with correct settings. If the mobile device is not set up or used correctly, you may not receive sensor glucose information or alerts. For complete details of the system and its components, including warnings, contraindications, and precautions, please consult the user guide and important safety information.